China Arthroscopy Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The China arthroscopy market encompasses devices used for minimally invasive diagnosis and treatment of joint conditions, primarily in knees and shoulders. With a 2025 valuation of roughly USD 387.3 million, the sector operates within a global market estimated at USD 6.67 billion to 7.84 billion in the same year. The market is positioned for steady expansion as China's healthcare infrastructure continues to modernize and patient access widens.

• •Market valued at approximately USD 387.3 million in 2025
• •China holds approximately 38% share of the Asia-Pacific arthroscopy market
• •Growth projected at 5.0% CAGR through 2030

The market expansion is fueled by multiple interconnected factors including demographic shifts and healthcare system evolution. An aging population, rising incidence of musculoskeletal disorders, and growing participation in sports have increased demand for arthroscopic procedures. Additionally, China's ongoing healthcare investments and rising disposable incomes are expanding patient access to advanced surgical options.

• •Increasing prevalence of joint-related disorders and orthopedic conditions
• •Expanding sports medicine sector and rising demand for minimally invasive procedures
• •Growth of outpatient surgical centers and broader healthcare infrastructure investments

The market can be segmented by product type and anatomical application. Arthroscope implants currently represent the largest product segment, while visualization systems are emerging as the fastest-growing category. Knee arthroscopy dominates application use, though shoulder procedures are recording the quickest growth rate.

• •Arthroscope implants constitute the largest product segment by revenue
• •Visualization systems represent the fastest-growing product category
• •Knee surgeries dominate application share, while shoulder surgeries show the fastest growth rate

What are the recent trends and outlook?

Technological innovation is reshaping product development priorities across the arthroscopy sector. The integration of artificial intelligence, 4K and 8K visualization technologies, and enhanced fluid management systems is driving the next generation of devices. These advancements, combined with rising procedural volumes, position the China market for sustained growth through 2030 and beyond.

• •Integration of AI and ultra-high-definition 4K/8K visualization systems into arthroscopic equipment
• •Advancements in radiofrequency ablation and fluid management technologies
• •Continued market expansion expected as minimally invasive techniques gain broader clinical acceptance